← Back to Clinical Trials
Recruiting NCT06543238

NCT06543238 Breastfeeding Education Using the Card Game Method

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06543238
Status Recruiting
Phase
Sponsor Çankırı Karatekin University
Condition Primiparity
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-09-09
Primary Completion 2025-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Breastfeeding card game group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-09-09 with a primary completion date of 2025-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to determine the effects of breastfeeding education using the card game method on breastfeeding success and breastfeeding self-efficacy in primiparous breastfeeding mothers.

Eligibility Criteria

Inclusion Criteria: * The conditions for volunteering to participate in the study are being over the age of 18, being able to read and write, being able to read and understand Turkish, not having hearing, speaking or visual impairments, having received breastfeeding training at a pregnancy school, being healthy in the 34th to 38th week of primiparous pregnancy, having a planned cesarean section, having a live birth and having a healthy baby. Exclusion Criteria: * Obstacles to communication include having a visual, hearing or perception disorder, not being able to read or write, having a psychiatric illness, being multiparous and having a vaginal birth, having a risky pregnancy, not having a live birth and not having a live baby after birth.

Contact & Investigator

Central Contact

Sakine Yılmaz

✉ sakinee_yilmaz@hotmail.com

📞 05439380626

Principal Investigator

Sakine Yılmaz

PRINCIPAL INVESTIGATOR

Çankırı Karatekin University

Frequently Asked Questions

Who can join the NCT06543238 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Primiparity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06543238 currently recruiting?

Yes, NCT06543238 is actively recruiting participants. Contact the research team at sakinee_yilmaz@hotmail.com for enrollment information.

Where is the NCT06543238 trial being conducted?

This trial is being conducted at Çankırı, Turkey (Türkiye).

Who is sponsoring the NCT06543238 clinical trial?

NCT06543238 is sponsored by Çankırı Karatekin University. The principal investigator is Sakine Yılmaz at Çankırı Karatekin University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology